HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Tohyama Selected Research

M Tohyama Research Topics

Disease

6Hypoxia (Hypoxemia)
06/2003 - 06/2000
5Hypersensitivity (Allergy)
08/2014 - 11/2001
5Alzheimer Disease (Alzheimer's Disease)
06/2003 - 12/2000
2Fasciculation (Fasciculations)
04/2007 - 07/2003
2Neuroblastoma
07/2004 - 12/2000
2Ischemia
03/2001 - 03/2000
1Chondrodysplasia Punctata (Stippled Epiphyses)
11/2018
1Drug Hypersensitivity Syndrome
08/2014
1X-Linked Mental Retardation (Mental Retardation, X Linked)
07/2012
1Exanthema (Rash)
02/2012
1Erythema
02/2012
1Inflammation (Inflammations)
09/2010
1Mental Disorders (Mental Disorder)
04/2007
1Eczema
04/2005
1Wounds and Injuries (Trauma)
01/2004
1Cold Urticaria
08/2002
1Urticaria (Hives)
08/2002
1Hypothermia
11/2001
1Drug Eruptions (Drug Eruption)
11/2001
1Infections
11/2001
1Cryptococcosis
11/2001
1Starvation
04/2001
1Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2001
1Fibrosis (Cirrhosis)
04/2001
1Interstitial Lung Diseases (Interstitial Lung Disease)
04/2001
1Stomach Neoplasms (Stomach Cancer)
10/2000
1Neoplasms (Cancer)
10/2000
1Brain Ischemia (Cerebral Ischemia)
05/2000
1Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2000
1Insulin Resistance
03/2000

Drug/Important Bio-Agent (IBA)

8Proteins (Proteins, Gene)FDA Link
07/2012 - 04/2000
4Presenilin-1IBA
11/2001 - 03/2000
2Anticonvulsants (Antiepileptic Drugs)IBA
03/2008 - 08/2006
2ApolipoproteinsIBA
02/2001 - 03/2000
1SterolsIBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1Chemokine CCL17IBA
08/2014
1ParaffinIBA
02/2012
1Keratin-10IBA
09/2010
1Fas Ligand Protein (Fas Ligand)IBA
09/2008
1DNA (Deoxyribonucleic Acid)IBA
03/2008
1kendrinIBA
04/2007
1Complementary DNA (cDNA)IBA
04/2007
1XylitolIBA
04/2005
1Calcium IonophoresIBA
07/2004
1Calcimycin (A23187)IBA
07/2004
1glucose-regulated proteinsIBA
07/2004
1rho-Associated KinasesIBA
01/2004
1Presenilin-2IBA
06/2003
1Protein Isoforms (Isoforms)IBA
06/2003
1RNA Precursors (Precursor, mRNA)IBA
06/2003
1RNA Splicing FactorsIBA
06/2003
1Cholinergic Agents (Cholinergics)IBA
08/2002
1Flavin-Adenine Dinucleotide (FAD)IBA
11/2001
1Interleukin-4 (Interleukin 4)IBA
11/2001
1Endoplasmic Reticulum Chaperone BiPIBA
11/2001
14-hydroxybenzoic acid diglycidyl etherIBA
11/2001
1Interferon-gamma (Interferon, gamma)IBA
11/2001
1Interleukin-18 (Interleukin 18)IBA
11/2001
1Interleukin-12 (IL 12)IBA
11/2001
1alpha-galactosylceramideIBA
11/2001
1CalciumIBA
04/2001
1Glucose (Dextrose)FDA LinkGeneric
04/2001
1Molecular Chaperones (Chaperone, Molecular)IBA
04/2001
1Hormones (Hormone)IBA
04/2001
1Circulating Thymic FactorIBA
04/2001
1CytokinesIBA
04/2001
1Bleomycin (Blenoxane)FDA LinkGeneric
04/2001
1ChemokinesIBA
04/2001
1Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2001
1Oxygen (Dioxygen)IBA
03/2001
1Phosphotransferases (Kinase)IBA
02/2001
1Insulin (Novolin)FDA Link
02/2001
1CaspasesIBA
02/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2001
1Apolipoprotein E4IBA
02/2001
1Amyloid beta-PeptidesIBA
12/2000
1Degenerin Sodium ChannelsIBA
10/2000
1Carcinoembryonic AntigenIBA
10/2000
1Liposomes (Liposome)IBA
10/2000
1Cytochromes c (Cytochrome c)IBA
08/2000
1NF-kappa B (NF-kB)IBA
08/2000
1ClusterinIBA
06/2000
1AntigensIBA
06/2000
1Aquaporins (Water Channels)IBA
05/2000
1Messenger RNA (mRNA)IBA
05/2000
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
04/2000
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
04/2000
1vascular factorIBA
03/2000
1PresenilinsIBA
03/2000

Therapy/Procedure

1Therapeutics
10/2000